Oil Is Heading For Its Worst Week In Months. Why Are Tanker Stocks Still Rising?
Featured , Jun 18, 2026, BY Surbhi Jain

The Middle East trade may be entering a new phase. Oil prices have retreated sharply this week as signs of progress in U.S.-Iran talks eased some fears of a broader regional disruption. The United States Oil Fund (NYSE:USO), one of the most widely followed proxies for crude oil prices, has fallen nearly 15% over the past five trading days. Yet many tanker and shipping stocks are refusing to follow oil lower. Frontline Plc (NYSE:FRO) is up 3.5% over the same period, while Scorpio Tankers Inc (NYSE:STNG) has gained 0.7% and Teekay Tankers Ltd. (NYSE:TNK) remains in positive territory. Broader shipping…

‘Big Short’ Investor Steve Eisman Is Hesitant About GOOGL, MSFT, But Bets On These Three Sectors
Featured , Jun 15, 2026
Featured, Jun 11, 2026
What’s Going On With AMD Stock Thursday?

Advanced Micro Devices, Inc. (NASDAQ:AMD) stock rose more than 2% in Thursday’s premarket session as semiconductor stocks advanced alongside stronger equity futures and renewed optimism around artificial intelligence infrastructure spending. The move comes after Bank of America Securities (BofA) analyst…

Featured, Jun 10, 2026
What’s Going On With Amazon Stock Wednesday?

On Wednesday, Amazon.com Inc. (NASDAQ:AMZN) expanded its less-than-truckload (LTL) freight service across the U.S., allowing businesses of all sizes to ship palletized freight to warehouses, distribution centers, and retail partners beyond Amazon’s network. The service, part of Amazon Supply Chain…

Featured, Jun 08, 2026
Apple, SUNation Energy, Tango Therapeutics, Applied Digital And Cerebras Systems: Why These 5 Stocks Are On Investors’ Radars Today

Major U.S. stock indexes finished Monday on a mixed note. The Dow Jones Industrial Average slipped 0.16% to 50,786.01, while the S&P 500 gained 0.30% to close at 7,405.73 and the Nasdaq advanced 0.86% to 25,929.66. These are the top…

Featured, Jun 05, 2026
Why Is BioCardia Stock Gaining Friday?

BioCardia Inc. (NASDAQ:BCDA) stock is up on Friday as the company is confirming progress toward potential market approval for its CardiAMP cell therapy. The positive movement follows the FDA’s acknowledgment that the ongoing CardiAMP Heart Failure II Trial may support…